A medical device developed at the University of Iowa that assists impaired hospital patients communicate with health care providers recently received regulatory clearance from the U.S. Food and Drug Administration (FDA). The device, called the noddle, was developed by UI Communication Sciences and Disorders Professor Emeritus Richard Hurtig, now Chief Scientific Officer of the parent company Voxello.

University of Iowa affiliated companies Behavioral Diagnostics and CartilaGen are two of a dozen emerging startup companies selected to compete at the Partnering for Growth’s Biotech Innovation Showcase on March 21 in Ankeny, Iowa. The companies selected represent a cross section of biotech industry including agricultural technology, human health, animal health and bio materials.